Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical

1. Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015 (Type, Mode of action, Crop Type and Geography) - Size, Share, Global and China and China Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 • TELEPHONE: +1 (855) 711-1555E-MAIL: help@researchbeam.com Published on : Oct 2014

2. Report Overview Summary “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides data on the Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non Alcoholic Fatty Liver Disease (NAFLD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non Alcoholic Fatty Liver Disease (NAFLD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

3. Report Overview • Scope • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type • Listings of discontinued trials (suspended, withdrawn and terminated) • Reasons to buy • Understand the dynamics of a particular indication in a condensed manner • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more • Obtain discontinued trial listing for trials across the globe • Espy the commercial landscape of the major Universities / Institutes / Hospitals

4. Tables of Contents Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Non Alcoholic Fatty Liver Disease (NAFLD) 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14

5. FOR MORE DETAILS Enquire About Report: http://www.researchbeam.com/non-alcoholic-fatty-liver-disease-nafld-global-clinical-trials-review-h1-2015-market/enquire-about-report Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeaam.com